Dataset Information


REV7 is required for processing AID initiated DNA lesions in activated B cells.

ABSTRACT: Activation-induced cytidine deaminase (AID) initiates both antibody class switch recombination (CSR) and somatic hypermutation (SHM) in antibody diversification. DNA double-strand break response (DSBR) factors promote rearrangement in CSR, while translesion synthesis (TLS) polymerases generate mutations in SHM. REV7, a component of TLS polymerase zeta, is also a downstream effector of 53BP1-RIF1 DSBR pathway. Here, we study the multi-functions of REV7 and find that REV7 is required for the B cell survival upon AID-deamination, which is independent of its roles in DSBR, G2/M transition or REV1-mediated TLS. The cell death in REV7-deficient activated B cells can be fully rescued by AID-deficiency in vivo. We further identify that REV7-depedent TLS across UNG-processed apurinic/apyrimidinic sites is required for cell survival upon AID/APOBEC deamination. This study dissects the multiple roles of Rev7 in antibody diversification, and discovers that TLS is not only required for sequence diversification but also B cell survival upon AID-initiated lesions.


PROVIDER: S-EPMC7272641 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC2572969 | BioStudies
2017-01-01 | S-EPMC5771415 | BioStudies
2018-01-01 | S-EPMC5884117 | BioStudies
2015-01-01 | S-EPMC4604686 | BioStudies
2015-01-01 | S-EPMC4751889 | BioStudies
2013-01-01 | S-EPMC3600397 | BioStudies
2011-01-01 | S-EPMC3065114 | BioStudies
2014-01-01 | S-EPMC4322776 | BioStudies
1000-01-01 | S-EPMC4260585 | BioStudies
2018-01-01 | S-EPMC5871760 | BioStudies